WOL071-007

· Dr. August Wolff GmbH & Co. KG Arzneimittel

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for WOL071-007, covering 2015-10-16 to 2015-10-16. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability, Pharmacokinetics and Efficacy of WOL071-007 in Atopic Dermatitis Patients [Phase 1]